Characterizing the landscape and impact of infections following kidney transplantation

被引:34
作者
Jackson, Kyle R. [1 ]
Motter, Jennifer D. [1 ]
Bae, Sunjae [1 ]
Kernodle, Amber [1 ]
Long, Jane J. [1 ]
Werbel, William [2 ]
Avery, Robin [2 ]
Durand, Christine [2 ]
Massie, Allan B. [1 ]
Desai, Niraj [1 ]
Garonzik-Wang, Jacqueline [1 ]
Segev, Dorry L. [1 ,3 ,4 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Sch Med, Div Infect Dis, Baltimore, MD 21205 USA
[3] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA
[4] Sci Registry Transplant Recipients, Minneapolis, MN 55404 USA
关键词
RENAL-ALLOGRAFT RECIPIENTS; SURGICAL SITE INFECTION; RISK-FACTORS; PNEUMONIA; MORTALITY; HOSPITALIZATION; REJECTION; BACTERIAL; SURVIVAL; OUTCOMES;
D O I
10.1111/ajt.16106
中图分类号
R61 [外科手术学];
学科分类号
摘要
Infections remain a major threat to successful kidney transplantation (KT). To characterize the landscape and impact of post-KT infections in the modern era, we used United States Renal Data System (USRDS) data linked to the Scientific Registry of Transplant Recipients (SRTR) to study 141 661 Medicare-primary kidney transplant recipients from January 1, 1999 to December 31, 2014. Infection diagnoses were ascertained by International Classification of Diseases, Ninth Revision (ICD-9) codes. The cumulative incidence of a post-KT infection was 36.9% at 3 months, 53.7% at 1 year, and 78.0% at 5 years. The most common infections were urinary tract infection (UTI; 46.8%) and pneumonia (28.2%). Five-year mortality for kidney transplant recipients who developed an infection was 24.9% vs 7.9% for those who did not, and 5-year death-censored graft failure (DCGF) was 20.6% vs 10.1% (P < .001). This translated to a 2.22-fold higher mortality risk (adjusted hazard ratio [aHR]:(2.15)2.22(2.29),P < .001) and 1.92-fold higher DCGF risk (aHR:(1.84)1.91(1.98),P < .001) for kidney transplant recipients who developed an infection, although the magnitude of this higher risk varied across infection types (for example, 3.11-fold higher mortality risk for sepsis vs 1.62-fold for a UTI). Post-KT infections are common and substantially impact mortality and DCGF, even in the modern era. Kidney transplant recipients at high risk for infections might benefit from enhanced surveillance or follow-up to mitigate these risks.
引用
收藏
页码:198 / 207
页数:10
相关论文
共 41 条
[11]   Risk factors for hospitalization for bacterial or viral infection in renal transplant recipients - An analysis of USRDS data [J].
Dharnidharka, V. R. ;
Agodoa, L. Y. ;
Abbott, K. C. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (03) :653-661
[12]   Infection in surgical patients: Effects on mortality, hospitalization, and postdischarge care [J].
DiPiro, JT ;
Martindale, RG ;
Bakst, A ;
Vacani, PF ;
Watson, P ;
Miller, MT .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (08) :777-781
[13]   Pneumonia After Kidney Transplant: Incidence, Risk Factors, and Mortality [J].
Dizdar, Oguzhan Sitki ;
Ersoy, Alparslan ;
Akalin, Halis .
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2014, 12 (03) :205-211
[14]   Accuracy of ICD-9-CM codes in identifying infections of pneumonia and herpes simplex virus in administrative data [J].
Drahos, Jennifer ;
Vanwormer, Jeffrey J. ;
Greenlee, Robert T. ;
Landgren, Ola ;
Koshiol, Jill .
ANNALS OF EPIDEMIOLOGY, 2013, 23 (05) :291-293
[15]   Kidney Allograft Survival After Acute Rejection, the Value of Follow-Up Biopsies [J].
El Ters, M. ;
Grande, J. P. ;
Keddis, M. T. ;
Rodrigo, E. ;
Chopra, B. ;
Dean, P. G. ;
Stegall, M. D. ;
Cosio, F. G. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (09) :2334-2341
[16]   Infection in Organ Transplantation [J].
Fishman, J. A. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (04) :856-879
[17]   Mortality Attributable to Hospital-Acquired Infections Among Surgical Patients [J].
Geffers, Christine ;
Sohr, Dorit ;
Gastmeier, Petra .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (12) :1167-1170
[18]   Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? [J].
Gordon, SM ;
LaRosa, SP ;
Kalmadi, S ;
Arroliga, AC ;
Avery, RK ;
Truesdell-LaRosa, L ;
Longworth, DL .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (02) :240-246
[19]   Health care-associated infections - an overview [J].
Haque, Mainul ;
Sartelli, Massimo ;
McKimm, Judy ;
Abu Bakar, Muhamad .
INFECTION AND DRUG RESISTANCE, 2018, 11 :2321-2333
[20]   Successful management of pulmonary tuberculosis in renal allograft recipients in a single center [J].
Jha, V ;
Sakhuja, V ;
Gupta, D ;
Krishna, VS ;
Chakrabarti, A ;
Joshi, K ;
Sud, K ;
Kohli, HS ;
Gupta, KL .
KIDNEY INTERNATIONAL, 1999, 56 (05) :1944-1950